Pharma-Bio Serv, Inc. Receives Presidential Award for Exports
03 Junho 2014 - 5:00PM
Marketwired
Pharma-Bio Serv, Inc. Receives Presidential Award for Exports
WASHINGTON, DC--(Marketwired - Jun 3, 2014) - U.S. Secretary of
Commerce Penny Pritzker on May 28, 2014 presented Pharma-Bio Serv,
Inc. (OTCQB: PBSV) with the President's "E" Award for Exports at a
ceremony in Washington, D.C. The "E" Awards are the highest
recognition any U.S. entity may receive for making a significant
contribution to the expansion of U.S. exports.
"We are honored to receive the 'E' Award," said Ms. Elizabeth
Plaza, Principal Executive Officer of Pharma-Bio Serv. "When we
first began exporting in 2008, export services accounted for two
percent of our total service revenue. During the past five years,
export services grew to approximately eleven percent of our total
service revenue, enabling us to sustain jobs and even expand our
workforce."
"Pharma-Bio Serv has demonstrated a sustained commitment to
export expansion. The 'E' Awards Committee was very impressed with
Pharma-Bio Serv's work to expand into emerging markets. The
company's dedication to growing the exporter base within its
community, especially minority business, was also particularly
impressive. Pharma-Bio Serv's achievements have undoubtedly
contributed to national export expansion efforts that support the
U.S. economy and create American jobs," said Secretary Pritzker in
her congratulatory letter to the company announcing its selection
as an award recipient.
U.S. exports of goods and services hit an all-time record of
$2.3 trillion in 2013. Nationally, jobs supported by exports
reached more than 11 million last year, up 1.6 million since 2009.
Launched earlier this month, NEI/Next, a new phase of President
Obama's National Export Initiative, works to boost economic growth
and support additional American jobs by assisting more U.S.
companies of all sizes in exporting to more markets across the
globe.
President Kennedy revived the World War II "E" symbol of
excellence to honor and provide recognition to America's exporters.
The "E" Award Program was established by Executive Order 10978 on
December 5, 1961. Four years of successive export growth and an
applicant's demonstration of an innovative international marketing
plan that led to the increase in exports is a significant factor in
making the award.
U.S. companies are nominated for the "E" Award for Exports
through the Department of Commerce's U.S. and Foreign Commercial
Service office network, located within the Department's
International Trade Administration, which has offices in 108 U.S.
cities and more than 70 countries to help U.S. exporters.
A total of 66 U.S. companies were presented with the President's
"E" Award this year.
About Pharma-Bio Serv Inc.
Pharma-Bio Serv is a compliance, project management and
technology transfer support consulting firm, headquartered in
Puerto Rico, with operations in the U.S., Ireland and Spain.
Pharma-Bio Serv's core business is FDA and international agencies
regulatory compliance related services with integrated portfolio
services including microbiological and chemical testing services
for clients in the Pharmaceutical, Biotechnology, Chemical, Medical
Device, Cosmetic, Food and Allied Products industries, at its
laboratory testing facility in Puerto Rico. Services also include
"Integratek," an information technology consulting practice, and
"Pharma Serv Academy" a division that provides technical and
regulatory standards seminars/training conducted by industry
experts. The Company's global team includes more than 300 leading
engineering and life science professionals, quality assurance
managers and directors.
Forward-Looking Statements
This news release contains "forward-looking statements" within
the meaning of the U.S. federal securities laws, which statements
may include information regarding the plans, intentions,
expectations, future financial performance, or future operating
performance of Pharma-Bio Serv. Forward-looking statements are
based on the expectations, estimates, or projections of management
as of the date of this news release. Although Pharma-Bio Serv's
management believes these expectations, estimates, or projections
to be reasonable as of the date of this news release,
forward-looking statements are inherently subject to significant
business risks, economic and competitive uncertainties, or other
contingencies, which could cause its actual results or performance
to differ materially from what may be expressed or implied in the
forward-looking statements. Important factors that could cause
Pharma-Bio Serv's actual results or performance to differ
materially from the forward-looking statements include those set
forth in the "Risk Factors" section of Pharma-Bio Serv's Annual
Report on Form 10-K for the year ended October 31, 2013 and in its
other filings with the Securities and Exchange Commission, which
filings are available on www.sec.gov. Pharma-Bio Serv disclaims any
intention or obligation to update or revise any forward-looking
statements to reflect subsequent events and circumstances, except
to the extent required by applicable law.
Investor Relations Contact: Scott Gordon President CorProminence
LLC scottg@corprominence.com 631 703 4900
Pharma Bio Serv (QB) (USOTC:PBSV)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Pharma Bio Serv (QB) (USOTC:PBSV)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
